Trial Profile
Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms P @ Work
- Sponsors AbbVie
- 12 Mar 2020 Status changed from active, no longer recruiting to completed.
- 08 Sep 2019 Planned number of patients changed from 760 to 360.
- 08 Sep 2019 Planned End Date changed from 31 Dec 2021 to 16 Feb 2020.